Threats to the Value of Health Technology Assessment: Qualitative Evidence From Canada and Poland

被引：0
|
作者：
Wranik, Wieslawa Dominika [1 ]
Gambold, Liesl [1 ]
Zielinska, Dorota [2 ]
Sevgur, Serperi [1 ]
机构：
[1] Dalhousie Univ, Halifax, NS, Canada
[2] Univ Warsaw, Warsaw, Poland
来源：
INTERNATIONAL JOURNAL OF QUALITATIVE METHODS | 2019年 / 18卷
关键词：
D O I：
暂无
中图分类号：
C [社会科学总论];
学科分类号：
03 ; 0303 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] HEALTH TECHNOLOGY ASSESSMENT IN POLAND AND SCOTLAND: COMPARISON OF PROCESS AND DECISIONS
    Kolasa, Katarzyna
    Wasiak, Radek
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012, 28 (01) : 70 - 76
  • [32] Stakeholders' Involvement in Health Technology Assessment in Kazakhstan, Poland and Bulgaria
    Kulembekova, Lyazzat
    Hailey, David
    Kulzhanov, Maksut
    Tabarov, Adlet
    Georgiev, Svetlin
    Jaworzynska, Magdalena
    Yanakieva, Antoniya Yordanova
    Kosherbayeva, Lyazzat
    PATIENT PREFERENCE AND ADHERENCE, 2024, 18 : 1009 - 1015
  • [33] Disseminating evidence from health technology assessment: The case of tobacco prevention
    Axelsson, Susanna
    Helgason, Asgeir R.
    Lund, Karl E.
    Adolfsson, Jan
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2006, 22 (04) : 500 - 505
  • [34] Uncertainty tolerance among experts involved in drug reimbursement recommendations: Qualitative evidence from HTA committees in Canada and Poland
    Wranik, Wieslawa Dominika
    Gambold, Liesl
    Peacock, Stuart
    HEALTH POLICY, 2021, 125 (03) : 307 - 319
  • [35] Striving for evidence in e-health evaluation: lessons from health technology assessment
    Gagnon, MP
    Scott, RE
    JOURNAL OF TELEMEDICINE AND TELECARE, 2005, 11 : 34 - 36
  • [36] From Health Technology Assessment to Health Technology Sustainability
    Iandolo, Francesca
    Vito, Pietro
    Fulco, Irene
    Loia, Francesca
    SUSTAINABILITY, 2018, 10 (12)
  • [37] Influencing Factors of Health Technology Assessment to Orphan Drugs: Empirical Evidence in England, Scotland, Canada, and Australia
    Zhou, Na
    Ji, Hong
    Li, Zheng
    Hu, Jun
    Xie, Jia-Hua
    Feng, Yu-Heng
    Yuan, Ni
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [38] Is health technology assessment value for money? Estimating the return on investment of health technology assessment in India (HTAIn)
    Bahuguna, Pankaj
    Baker, Peter Alan
    Briggs, Andrew
    Gulliver, Sophie
    Hesselgreaves, Hannah
    Mehndiratta, Abha
    Ruiz, Francis
    Tyagi, Kirti
    Wu, Olivia
    Guzman, Javier
    Grieve, Eleanor
    BMJ EVIDENCE-BASED MEDICINE, 2025,
  • [39] THE VALUE OF REAL-WORLD EVIDENCE (RWE) IN MELANOMA IN HEALTH TECHNOLOGY ASSESSMENT (HTA) APPRAISALS
    Shah, R.
    Gautam, R.
    Rai, M. K.
    Prasanna, R.
    VALUE IN HEALTH, 2022, 25 (12) : S317 - S317
  • [40] Obtaining value for money from pharmaceuticals:: Reference pricing or health technology assessment?
    Drummod, M. F.
    Joensson, B.
    Rutten, F.
    Stargardt, T.
    VALUE IN HEALTH, 2007, 10 (06) : A370 - A370
12345